GlassScriptPhysician profile
Scott S Carpenter
NPI 1326028036
$9,418.80
in general payments reported to CMS, 2019-2025
13 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,313 · 2020: $4,496 · 2021: $369 · 2024: $133 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,942.50 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $173.55 | 2024-2025 | Breztri, Farxiga, Airsupra |
| Ethicon US, LLC | $129.63 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $34.83 | 2025 | Fanapt |
| Endogastric Solutions, INC | $19.74 | 2019 | |
| Exact Sciences Corporation | $19.18 | 2025 | Cologuard Collection Kit |
| Organogenesis INC. | $17.48 | 2020 | |
| Innocoll Pharmaceuticals Limited | $15.58 | 2021 | |
| Bioventus LLC | $14.67 | 2020 | |
| Biogen, INC. | $14.21 | 2025 | Skyclarys |
| W. L. Gore & Associates, INC. | $13.25 | 2020 | |
| Allergan, INC. | $13.10 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.